3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
8
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Stomach Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
5
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Pancreatic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity
2
Meningioma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Surgical Wound Dehiscence
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Small Cell Lung Carcinoma
1
Skull Base Neoplasms
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Interventions
Gemcitabine
7
Oxaliplatin
6
Cisplatin
5
durvalumab
3
130-nm albumin-bound paclitaxel
3
pembrolizumab
2
Leucovorin
2
Drug Therapy
2
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
sintilimab
1
pertuzumab
1
anlotinib
1
Trastuzumab
1
Taxes
1
Standard of Care
1
Platinum
1
Observation
1
Nivolumab
1
Neoadjuvant Therapy
1
Long-Term Synaptic Depression
1
Irinotecan
1
Folfox protocol
1
Fluorouracil
1
Everolimus
1
Commerce
1
Cholangiopancreatography, Endoscopic Retrograde
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Gallbladder Neoplasms
×
Observation
×
Clear all
NCT06192719
2026-02-18
EULAT
Centre Paul Strauss
Recruiting
15,000 enrolled